Turkish Journal of Anaesthesiology and Reanimation, vol.50, no.3, pp.228-231, 2022 (Peer-Reviewed Journal)
Article / Article
Turkish Journal of Anaesthesiology and Reanimation
Scopus, TR DİZİN (ULAKBİM)
Antifibrotic, COVID-19, pirfenidone, pulmonary fibrosis, respiratory distress
© 2022, AVES. All rights reserved.Coronavirus disease 19 infection clinical presentation varies from asymptomatic cases to acute respiratory distress syndromes. In some cases, pulmonary fibrosis is observed after or during the disease. Pirfenidone is an agent approved for the treatment of idiopathic pulmonary fibrosis. Here we report a patient treated with pirfenidone for pulmonary fibrosis related to coronavirus disease 19.